Aqua Bio Technology ASA (OSL: ABTEC)
Norway
· Delayed Price · Currency is NOK 3.280
+0.480 (17.14%)
At close: Jan 17, 2025
Aqua Bio Technology ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Operating Revenue | 13.51 | 7.02 | 1.56 | 0.44 | 0.89 | 0.88 | Upgrade
|
| Other Revenue | 0.31 | 0.14 | 0.42 | 0.37 | 0.4 | 0.34 | Upgrade
|
| Revenue | 13.82 | 7.16 | 1.98 | 0.81 | 1.3 | 1.22 | Upgrade
|
| Revenue Growth (YoY) | 664.08% | 262.49% | 143.11% | -37.26% | 6.42% | -87.68% | Upgrade
|
| Cost of Revenue | 4.5 | 4.69 | 0.95 | 0.98 | 1.42 | 18.67 | Upgrade
|
| Gross Profit | 9.32 | 2.47 | 1.02 | -0.17 | -0.13 | -17.45 | Upgrade
|
| Selling, General & Admin | 19.56 | 17.17 | 17.79 | 15.82 | 12.73 | 16.58 | Upgrade
|
| Operating Expenses | 21.92 | 18.84 | 18.88 | 15.94 | 13 | 17.44 | Upgrade
|
| Operating Income | -12.61 | -16.37 | -17.86 | -16.1 | -13.12 | -34.89 | Upgrade
|
| Interest Expense | -3.62 | -2.24 | -1.46 | -0 | -0.03 | -0.05 | Upgrade
|
| Interest & Investment Income | - | 0 | - | 0 | 0.01 | 0.08 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.15 | -0.15 | 0.2 | -0.06 | -0.11 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | 1.21 | 0.04 | - | Upgrade
|
| EBT Excluding Unusual Items | -16.37 | -18.75 | -19.11 | -14.95 | -13.22 | -34.88 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -3.58 | Upgrade
|
| Pretax Income | -1.46 | -18.75 | -19.11 | -14.95 | -13.22 | -38.47 | Upgrade
|
| Income Tax Expense | 0.04 | -0.02 | - | -0.25 | - | - | Upgrade
|
| Net Income | -1.5 | -18.74 | -19.11 | -14.7 | -13.22 | -38.47 | Upgrade
|
| Net Income to Common | -1.5 | -18.74 | -19.11 | -14.7 | -13.22 | -38.47 | Upgrade
|
| Shares Outstanding (Basic) | 21 | 21 | 19 | 16 | 13 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 21 | 19 | 16 | 13 | 7 | Upgrade
|
| Shares Change (YoY) | 3.21% | 7.88% | 18.67% | 25.77% | 85.41% | - | Upgrade
|
| EPS (Basic) | -0.07 | -0.91 | -0.99 | -0.91 | -1.03 | -5.54 | Upgrade
|
| EPS (Diluted) | -0.09 | -0.92 | -0.99 | -0.91 | -1.03 | -5.54 | Upgrade
|
| Free Cash Flow | -9.71 | -15.45 | -20.97 | -13.47 | -17.21 | -17.24 | Upgrade
|
| Free Cash Flow Per Share | -0.47 | -0.75 | -1.09 | -0.83 | -1.34 | -2.48 | Upgrade
|
| Gross Margin | 67.43% | 34.52% | 51.82% | -20.78% | -9.72% | - | Upgrade
|
| Operating Margin | -91.23% | -228.56% | -903.89% | -1981.81% | -1013.33% | -2866.59% | Upgrade
|
| Profit Margin | -10.88% | -261.62% | -967.45% | -1809.43% | -1020.35% | -3160.65% | Upgrade
|
| Free Cash Flow Margin | -70.29% | -215.73% | -1061.42% | -1657.67% | -1328.94% | -1416.91% | Upgrade
|
| EBITDA | -11.11 | -15.13 | -16.9 | -15.99 | -13 | -34.11 | Upgrade
|
| EBITDA Margin | -80.42% | -211.29% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 1.49 | 1.24 | 0.96 | 0.11 | 0.12 | 0.78 | Upgrade
|
| EBIT | -12.61 | -16.37 | -17.86 | -16.1 | -13.12 | -34.89 | Upgrade
|
| EBIT Margin | -91.23% | -228.56% | - | - | - | - | Upgrade
|
| Revenue as Reported | 13.82 | 7.16 | 1.98 | 0.81 | 1.3 | 1.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.